Subject: One little stock that's definitely on the rise.  See for yourself.
Message-ID: <e265fdb5feceacc9f80f6ee49e41364d622.321.39938473.234453@lowellmsmithrealty.sitnotraj.com>
From: Exciting Penny Pick <Skylar@sitnotraj.com>
Date: Tue, 23 Sep 2014 07:41:51 -0700
To: <lojban@lojban.org>
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit
MIME-Version: 1.0
X-Spam_score: 2.0
X-Spam_score_int: 20
X-Spam_bar: ++
X-Spam-Report: Spam detection software, running on the system "stodi.digitalkingdom.org", has
 identified this incoming email as possible spam.  The original message
 has been attached to this so you can view it (if it isn't spam) or label
 similar future email.  If you have any questions, see
 the administrator of that system for details.
 
 Content preview:  Tuesday 09-23-2014 06:01:26 POSC This pick made gains of almost
    20% yesterday. Please use any service to check the validity of these statements.
    You're favorite trading firm, Google, Yahoo, anwywhere. [...] 
 
 Content analysis details:   (2.0 points, 5.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
 -0.7 RP_MATCHES_RCVD        Envelope sender domain matches handover relay domain
 -1.9 BAYES_00               BODY: Bayes spam probability is 0 to 1%
                             [score: 0.0000]
  1.0 PUMPDUMP               Pump-and-dump stock scam phrase
  0.0 LOTS_OF_MONEY          Huge... sums of money
  3.6 MONEY_FRAUD_3          Lots of money and several fraud phrases

Tuesday
09-23-2014 06:01:26

POSC    


This pick made gains of almost 20% yesterday.  Please use any service to check the validity of these statements.   You're favorite trading firm, Google, Yahoo, anwywhere.

That's POSC


It's an exciting Sub=Penny stock for you to read about right now.

At these levels there could be some explosive gains so put this stock on your radar right now.

We have never recommended a stock with this much insider buying.

Our announcement today is on:  POSC (Positron Corp.)

Add POSC to your hot stock list. This stock can really move!

The stock has been no stranger to double and triple digit gains in one day and it even produced gains as high as 100% in hours! Earlier this year POSC went from $.006 to $.012 in one day...a gain of 100%!!
Before we get into details about the life saving technology Positron Corp (POSC) offers, please check out the link below from the Nasdaq website.  It lists that two of its officers of POSC have bought 100's of millions of shares of POSC in the last few months.   Everyone knows that insider buying is one of the strongest bullish signals investors use!

 
The story:
Heart disease is the #1 killer of people in the US.   Positron designs and markets a newer technology for the early detection of heart disease.  The new technology is Cardiac Positron Emission Tomography known as (Cardiac PET).
Cardiac PET is a first line defense for determining if a person is at risk for life threatening heart issues, as Cardiac PET scans can detect over 95 percent of people who have significant blockages of coronary arteries and produce reliably normal results in over 95 percent of people with no heart disease.
Cardiac PET is used to evaluate the chemical function of tissues and organs, while older imaging techniques  such as X-ray, CT and MRI scans  show structure. For the detection of coronary artery disease, Cardiac PET technology is particularly useful, due to its ability to highlight functional issues of the heart.
ADVANTAGES OF Cardiac PET over older technologies:
 Better Economics
 Improved Efficiency
 Lower Radiation Exposure
 Fewer Attenuation Artifacts (leads to better results)
 Improved Resolution
 
Industry Overview:
 
 Cardiac PET equipment market is expected to grow from $26 Million to 
$47 Million by 2015....and then at least 20% every year after that. 
 
 Cardiovascular disease (CVD) is the leading cause of death in the U.S. 
Direct CVD costs are expected to be $818 Billion by 2030. 
 
 U.S. Market for diagnostic imaging is expected to reach $6 Billion by 2018. Cardiac PET is expected to grow to 72% ($4.31 Billion) of that market!!


Company Overview:
 
1.  Positron's Attricus PET system was the recipient on the North American Molecular Imaging Systems New Product Innovation Award by industry leading research firm, Frost and Sullivan.
 
2.  Huge insider buying at these levels. 
 
3.  New CEO who is a pioneer in the Cardiac PET research and procedure field.
 
4.  A stock that has explosive ability to double in a single day!!!
 
As you can see, the demand for imaging products such as the ones that Positron Corp sells is going to be HUGE....and Positron is well positioned to participate in the demand.    This is a huge buying opportunity right at only $.004!!!
 
Please take the time to review the company's website at positron.com
 
 
 Aster-Originating Services Center definitely does not want to send you or anyone email to you or anyone that do not wish to get it.
 Please use this URL:  
 http://www.sitnotraj.com/0iff.w3rj
 Or send Regular Postal Letter to: 
 6629 West Randolph Cnty Ln Rd	
 Lynn, 
 Indiana 47355    ATTN: End Com
 
 
General Notice.  Disclaimer.  Please read through very carefully.
 
We are primarily engaged in the business of marketing and advertising companies for monetary compensation.  At times we will profile a company without receiving any compensation for the purpose of increasing readership.  Aster-Originating Services Center has NOT been compensated for this profile of Positron Corp. (POSC).
 
All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Aster-Originating Services Center sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Aster-Originating Services Center or an offer or solicitation to buy or sell any securities.
None of the owners of Aster-Originating Services Center, or any of its members, officers, directors, contractors or employees is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Aster-Originating Services Center makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Aster-Originating Services Center makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Aster-Originating Services Center  has no obligation to update any of the information provided, nor is it responsible for errors and omissions.
From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our releases or on our website may not have approved certain or any statements within the release or website. Aster-Originating Services Center  encourages viewers to supplement the information obtained from any release or our website with independent research and other professional advice. By accessing, viewing, or using our website or communications originating from our website or any release therein, you agree that Aster-Originating Services Center, its owners, officers, directors, contractors and employees, are not responsible for any content.

Thank you,

Aster Management
09-23-2014 06:01:26

A positron emission tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity.

The tracer may be injected, swallowed or inhaled, depending on which organ or tissue is being studied by the PET scan. The tracer collects in areas of your body that have higher levels of chemical activity, which often correspond to areas of disease. On a PET scan, these areas show up as bright spots.

A PET scan is useful in revealing or evaluating several conditions, including some cancers, heart disease and brain disorders.


A PET scan uses a small amount of radioactive material (tracer). The  tracer is given through a vein (IV), most often on the inside of your elbow. The tracer travels through your blood and collects in organs and tissues. This helps the radiologist see certain areas of concern more clearly.

You will need to wait nearby as the tracer is absorbed by your body. This takes about 1 hour.

Then, you will lie on a narrow table that slides into a large tunnel-shaped scanner. The PET detects signals from the tracer. A computer changes the signals into 3-D pictures. The images are displayed on a monitor for your doctor to read.

You must lie still during test. Too much movement can blur images and cause errors.

How long the test takes depends on what part of the body is being scanned.

How to Prepare for the Test
You may be asked not to eat anything for 4 - 6 hours before the scan. You will be able to drink water.

Tell your health care provider if:

You are afraid of close spaces (have claustrophobia). You may be given a medicine to help you feel sleepy and less anxious.
You are pregnant or think you might be pregnant.
You have any allergies to injected dye (contrast).
Always tell your health care provider about the medicines you are taking, including those bought without a prescription. Sometimes, medications may interfere with the test results.

How the Test will Feel
You may feel a sharp sting when the needle with the tracer is placed into your vein.

A PET scan causes no pain. The table may be hard or cold, but you can request a blanket or pillow.

An intercom in the room allows you to speak to someone at any time.

There is no recovery time, unless you were given a medicine to relax.

What is PET?

Positron emission tomography (PET) is a specialized radiology procedure used to examine various body tissues to identify certain conditions. PET may also be used to follow the progress of the treatment of certain conditions. While PET is most commonly used in the fields of neurology, oncology, and cardiology, applications in other fields are currently being studied.

PET is a type of nuclear medicine procedure. This means that a tiny amount of a radioactive substance, called a radionuclide (radiopharmaceutical or radioactive tracer), is used during the procedure to assist in the examination of the tissue under study. Specifically, PET studies evaluate the metabolism of a particular organ or tissue, so that information about the physiology (functionality) and anatomy (structure) of the organ or tissue is evaluated, as well as its biochemical properties. Thus, PET may detect biochemical changes in an organ or tissue that can identify the onset of a disease process before anatomical changes related to the disease can be seen with other imaging processes, such as computed tomography (CT) or magnetic resonance imaging (MRI).

PET is most often used by oncologists (doctors specializing in cancer treatment), neurologists and neurosurgeons (doctors specializing in treatment and surgery of the brain and nervous system), and cardiologists (doctors specializing in the treatment of the heart). However, as advances in PET technologies continue, this procedure is beginning to be used more widely in other areas.

PET is also being used in conjunction with other diagnostic tests such as computed tomography (CT) to provide more definitive information about malignant (cancerous) tumors and other lesions. The combination of PET and CT shows particular promise in the diagnosis and treatment of many types of cancer.

Until recently, PET procedures were performed in dedicated PET centers. The equipment used in these centers is quite expensive. However, a new technology called gamma camera systems (devices used to scan patients who have been injected with small amounts of radionuclides and currently in use with other nuclear medicine procedures) is now being adapted for use in PET scan procedures. The gamma camera system can complete a scan more quickly, and at less cost, than a traditional PET scan.

How does PET work?

PET works by using a scanning device (a machine with a large hole at its center) to detect positrons (subatomic particles) emitted by a radionuclide in the organ or tissue being examined.

The radionuclides used in PET scans are made by attaching a radioactive atom to chemical substances that are used naturally by the particular organ or tissue during its metabolic process. For example, in PET scans of the brain, a radioactive atom is applied to glucose (blood sugar) to create a radionuclide called fluorodeoxyglucose (FDG), because the brain uses glucose for its metabolism. FDG is widely used in PET scanning.

Other substances may be used for PET scanning, depending on the purpose of the scan. If blood flow and perfusion of an organ or tissue is of interest, the radionuclide may be a type of radioactive oxygen, carbon, nitrogen, or gallium.

The radionuclide is administered into a vein through an intravenous (IV) line. Next, the PET scanner slowly moves over the part of the body being examined. Positrons are emitted by the breakdown of the radionuclide. Gamma rays are created during the emission of positrons, and the scanner then detects the gamma rays. A computer analyzes the gamma rays and uses the information to create an image map of the organ or tissue being studied. The amount of the radionuclide collected in the tissue affects how brightly the tissue appears on the image, and indicates the level of organ or tissue function.

Other related procedures that may be performed include computed tomography (CT scan) and magnetic resonance imaging (MRI). Please see these procedures for additional information.

Reasons for the procedure

In general, PET scans may be used to evaluate organs and/or tissues for the presence of disease or other conditions. PET may also be used to evaluate the function of organs such as the heart or brain. Another use of PET scans is in the evaluation of the treatment of cancer.

More specific reasons for PET scans include, but are not limited to, the following:

To diagnose dementias such as Alzheimer's disease, as well as other neurological conditions such as Parkinson's disease (a progressive disease of the nervous system in which a fine tremor, muscle weakness, and a peculiar type of gait are seen), Huntington's disease (a hereditary disease of the nervous system which causes increasing dementia, bizarre involuntary movements, and abnormal posture), epilepsy (a brain disorder involving recurrent seizures), and cerebrovascular accident (stroke)

To locate the specific surgical site prior to surgical procedures of the brain

To evaluate the brain after trauma to detect hematoma (blood clot), bleeding, and/or perfusion (blood and oxygen flow) of the brain tissue

To detect the spread of cancer to other parts of the body from the original cancer site

To evaluate the effectiveness of cancer treatment

To evaluate the perfusion to the myocardium (heart muscle) as an aid in determining the usefulness of a therapeutic procedure to improve blood flow to the myocardium

To further identify lung lesions or masses detected on chest X-ray and/or chest CT

To assist in the management and treatment of lung cancer by staging lesions and following the progress of lesions after treatment

To detect recurrence of tumors earlier than with other diagnostic modalities

There may be other reasons for your doctor to recommend a PET scan.

Risks of the procedure

The amount of the radionuclide injected into your vein for the procedure is small enough that there is no need for precautions against radioactive exposure. The injection of the radionuclide may cause some slight discomfort. Allergic reactions to the radionuclide are rare, but may occur.

For some patients, having to lie still on the scanning table for the length of the procedure may cause some discomfort or pain.

Patients who are allergic to or sensitive to medications, contrast dyes, iodine, or latex should notify their doctor.

If you are pregnant or suspect that you may be pregnant, you should notify your health care provider due to the risk of injury to the fetus from a PET scan. If you are lactating, or breastfeeding, you should notify your health care provider due to the risk of contaminating breast milk with the radionuclide.

There may be other risks depending on your specific medical condition. Be sure to discuss any concerns with your doctor prior to the procedure.

Certain factors or conditions may interfere with the accuracy of a PET scan. These factors include, but are not limited to, the following:

High blood glucose levels in diabetics

Caffeine, alcohol, or tobacco consumed within 24 hours of the procedure

Medications, such as insulin, tranquilizers, and sedatives

Notify your doctor if any of the above situations may apply to you.

Before the procedure

Your doctor will explain the procedure and offer you the opportunity to ask any questions that you might have about the procedure.

You may be asked to sign a consent form that gives your permission to do the procedure. Read the form carefully and ask questions if something is not clear.

Notify the radiologist or technologist if you are allergic to latex and/or sensitive to medications, contrast dyes, or iodine.

Fasting for a certain period of time prior to the procedure is generally required. Your doctor will give you special instructions ahead of time as to the number of hours you are to withhold food and drink. Your doctor will also inform you as to the use of medications prior to the PET scan.

Notify your doctor if you are pregnant or suspect you may be pregnant.

Notify your doctor of all medications (prescribed and over-the-counter) and herbal supplements that you are taking.

You should not consume any caffeine or alcohol, or use tobacco, for at least 24 hours prior to the procedure.

If you are a diabetic who uses insulin, you may be instructed to take your preprocedure insulin dose with a meal several hours prior to the procedure. Your doctor will give you specific instructions based on your individual situation. Also, a fasting blood sugar test may be obtained prior to the procedure. If your blood sugar is elevated, you may be given insulin to lower the blood sugar.

Based on your medical condition, your doctor may request other specific preparation.

During the procedure

PET scans may be performed on an outpatient basis or as part of your stay in a hospital. Procedures may vary depending on your condition and your doctor's practices.

Generally, a PET scan follows this process:

 Photo of person about to receive PET Scan
PET Scan

You will be asked to remove any clothing, jewelry, or other objects that may interfere with the scan.

If you are asked to remove clothing, you will be given a gown to wear.

You will be asked to empty your bladder prior to the start of the procedure.

One or two intravenous (IV) lines will be started in the hand or arm for injection of the radionuclide.

Certain types of scans of the abdomen or pelvis may require that a urinary catheter be inserted into the bladder to drain urine during the procedure.

In some cases, an initial scan may be performed prior to the injection of the radionuclide, depending on the type of study being done. You will be positioned on a padded table inside the scanner.

The radionuclide will be injected into your vein. The radionuclide will be allowed to concentrate in the organ or tissue for about 30 to 60 minutes. You will remain in the facility during this time. You will not be hazardous to other people, as the radionuclide emits less radiation than a standard X-ray.

After the radionuclide has been absorbed for the appropriate length of time, the scan will begin. The scanner will move slowly over the body part being studied.

When the scan has been completed, the IV line will be removed. If a urinary catheter has been inserted, it will be removed.

While the PET scan itself causes no pain, having to lie still for the length of the procedure might cause some discomfort or pain, particularly in the case of a recent injury or invasive procedure, such as surgery. The technologist will use all possible comfort measures and complete the procedure as quickly as possible to minimize any discomfort or pain.

After the procedure

You should move slowly when getting up from the scanner table to avoid any dizziness or lightheadedness from lying flat for the length of the procedure.

You will be instructed to drink plenty of fluids and empty your bladder frequently for 24 to 48 hours after the test to help flush the remaining radionuclide from your body.

The IV site will be checked for any signs of redness or swelling. If you notice any pain, redness, and/or swelling at the IV site after you return home following your procedure, you should notify your doctor as this may indicate an infection or other type of reaction.

Your doctor may give you additional or alternate instructions after the procedure, depending on your particular situation.

Online resources

The content provided here is for informational purposes only, and was not designed to diagnose or treat a health problem or disease, or replace the professional medical advice you receive from your doctor. Please consult your health care provider with any questions or concerns you may have regarding your condition.

This page contains links to other websites with information about this procedure and related health conditions. We hope you find these sites helpful, but please remember we do not control or endorse the information presented on these websites, nor do these sites endorse the information contained here.

Alzheimer's Association

American Academy of Orthopaedic Surgeons

American Cancer Society

American Heart Association

American Stroke Association

Brain Injury Association of America

Epilepsy Foundation

National Cancer Institute (NCI)

National Institute of Neurological Disorders and Stroke

National Institutes of Health (NIH)

National Library of Medicine

Radiological Society of North America